Overview

Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States. The aim of this clinical trial is to investigate whether chronic liraglutide administration affects the mode of action (pharmacokinetics) of insulin detemir
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Liraglutide